Linkage of familial combined hyperlipidaemia to chromosome 1q21–q23

[1]  A. Lusis,et al.  Mapping a gene for combined hyperlipidaemia in a mutant mouse strain , 1998, Nature Genetics.

[2]  L. Peltonen,et al.  No evidence of linkage between familial combined hyperlipidemia and genes encoding lipolytic enzymes in Finnish families. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[3]  J. Rotter,et al.  Complex genetic contribution of the Apo AI-CIII-AIV gene cluster to familial combined hyperlipidemia. Identification of different susceptibility haplotypes. , 1997, The Journal of clinical investigation.

[4]  Leena Peltonen,et al.  A putative vulnerability locus to multiple sclerosis maps to 5p14–p12 in a region syntenic to the murine locus Eae2 , 1996, Nature Genetics.

[5]  M. Hayden,et al.  Lack of association of the apolipoprotein A-I-C-III-A-IV gene XmnI and SstI polymorphisms and of the lipoprotein lipase gene mutations in familial combined hyperlipoproteinemia in French Canadian subjects. , 1996, Journal of lipid research.

[6]  D. Kromhout,et al.  A frequently occurring mutation in the lipoprotein lipase gene (Asn291Ser) contributes to the expression of familial combined hyperlipidemia. , 1995, Human molecular genetics.

[7]  J. Terwilliger.  A powerful likelihood method for the analysis of linkage disequilibrium between trait loci and one or more polymorphic marker loci. , 1995, American journal of human genetics.

[8]  E. Wijsman,et al.  Genetic predictors of FCHL in four large pedigrees. Influence of ApoB level major locus predicted genotype and LDL subclass phenotype. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[9]  J. Viikari,et al.  Age and gender specific serum lipid and apolipoprotein fractiles of Finnish children and young adults. The Cardiovascular Risk in Young Finns Study , 1994, Acta paediatrica.

[10]  M. Farrall,et al.  Complex segregation analysis provides evidence for a major gene acting on serum triglyceride levels in 55 British families with familial combined hyperlipidemia. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[11]  A A Schäffer,et al.  Avoiding recomputation in linkage analysis. , 1994, Human heredity.

[12]  E. Vartiainen,et al.  Twenty-year trends in coronary risk factors in north Karelia and in other areas of Finland. , 1994, International journal of epidemiology.

[13]  J. Terwilliger.  Genetic Variation and Human Disease: Principles and Evolutionary Approaches , 1997 .

[14]  A. Chapelle,et al.  Disease gene mapping in isolated human populations: the example of Finland. , 1993, Journal of medical genetics.

[15]  A A Schäffer,et al.  Faster sequential genetic linkage computations. , 1993, American journal of human genetics.

[16]  P. Kwiterovich.  Genetics and molecular biology of familial combined hyperlipidemia , 1993 .

[17]  J D Terwilliger,et al.  A novel polylocus method for linkage analysis using the lod‐score or affected sib‐pair method , 1993, Genetic epidemiology.

[18]  A Sajantila,et al.  Identification of individuals by analysis of biallelic DNA markers, using PCR and solid-phase minisequencing. , 1993, American journal of human genetics.

[19]  S. Hodge,et al.  Inter- and intrafamilial heterogeneity: effective sampling strategies and comparison of analysis methods. , 1992, American journal of human genetics.

[20]  Richard H. Myers,et al.  Familial Lipoprotein Disorders in Patients With Premature Coronary Artery Disease , 1992, Circulation.

[21]  R. Krauss,et al.  Linkage of atherogenic lipoprotein phenotype to the low density lipoprotein receptor locus on the short arm of chromosome 19. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[22]  N Risch,et al.  Model misspecification and multipoint linkage analysis. , 1992, Human heredity.

[23]  M. Farrall,et al.  Familial combined hyperlipidaemia linked to the apolipoprotein AI–CIII–AIV gene cluster on chromosome 11q23q–q24 , 1991, Nature.

[24]  R. Krauss,et al.  Inheritance of low density lipoprotein subclass patterns in familial combined hyperlipidemia. , 1990, Arteriosclerosis.

[25]  M. E. Ramirez,et al.  Apolipoprotein, Low Density Lipoprotein Subtraction, and Insulin Associations with Familial Combined Hyperlipidemia: Study of Utah Patients with Familial Dyslipidemic Hypertension , 1989, Arteriosclerosis.

[26]  S. Grundy,et al.  Familial combined hyperlipidemia workshop , 1989 .

[27]  A. Lusis,et al.  Ath-1, a gene determining atherosclerosis susceptibility and high density lipoprotein levels in mice. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[28]  P. Lipsky,et al.  Detection of familial hypercholesterolemia by assaying functional low-density-lipoprotein receptors on lymphocytes. , 1986, The New England journal of medicine.

[29]  J. Ott.  Analysis of Human Genetic Linkage , 1985 .

[30]  J. Ott,et al.  Strategies for multilocus linkage analysis in humans. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[31]  R. Deitch.  Commentary from Westminster , 1981, The Lancet.

[32]  A. Motulsky,et al.  Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia. , 1973, The Journal of clinical investigation.

[33]  A. Aro,et al.  Family study of serum lipids and lipoproteins in coronary heart-disease. , 1973, Lancet.

[34]  Joseph L. Goldstein,et al.  Hyperlipidemia in Coronary Heart Disease , 1973 .